Evidence map›Paper›PMID 31856914›Full record

ArticleEpigenetics & chromatin2019

Comprehensive epigenome characterization reveals diverse transcriptional regulation across human vascular endothelial cells.

Ryuichiro Nakato, Youichiro Wada, Ryo Nakaki, Genta Nagae, Yuki Katou, Shuichi Tsutsumi, Natsu Nakajima, Hiroshi Fukuhara, Atsushi Iguchi, Takahide Kohro and 26 more

Open access · goldAbstract read
In one paragraph

Article in Epigenetics & chromatin, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Vascular mechanotransduction.Physiological reviews · 2023
    Review
  12. Review
  13. Article
  14. Primary Breast Angiosarcoma: Comparative Transcriptome Analysis.International journal of molecular sciences · 2022
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 6 institutions in 2 countries.

Ryuichiro NakatoLaboratory of Computational Genomics, Institute for Quantitative Biosciences, The University of Tokyo, Tokyo, 113-0032, Japan.ORCID 0000-0003-3019-5817
Youichiro WadaJapan Agency for Medical Research and Development (AMED-CREST), AMED, 1-7-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan. ywada-tky@umin.ac.jp.
Ryo NakakiGenome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, 153-8904, Japan.
Genta NagaeJapan Agency for Medical Research and Development (AMED-CREST), AMED, 1-7-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
Yuki KatouLaboratory of Genome Structure and Function, Institute for Quantitative Biosciences, The University of Tokyo, Tokyo, 113-0032, Japan.
Shuichi TsutsumiGenome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, 153-8904, Japan.
Natsu NakajimaLaboratory of Computational Genomics, Institute for Quantitative Biosciences, The University of Tokyo, Tokyo, 113-0032, Japan.
Hiroshi FukuharaDepartment of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan.
Atsushi IguchiDepartment of Cardiovascular Surgery, Saitama Medical University International Medical Center, Saitama, 350-1298, Japan.
Takahide KohroDepartment of Clinical Informatics, Jichi Medical University School of Medicine, Shimotsuke, 329-0498, Japan.
Yasuharu KankiJapan Agency for Medical Research and Development (AMED-CREST), AMED, 1-7-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
Yutaka SaitoJapan Agency for Medical Research and Development (AMED-CREST), AMED, 1-7-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
Mika KobayashiIsotope Science Center, The University of Tokyo, Tokyo, 113-0032, Japan.
Akashi Izumi-TaguchiIsotope Science Center, The University of Tokyo, Tokyo, 113-0032, Japan.
Naoki OsatoJapan Agency for Medical Research and Development (AMED-CREST), AMED, 1-7-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
Kenji TatsunoGenome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, 153-8904, Japan.
Asuka KamioGenome Science Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, 153-8904, Japan.
Yoko Hayashi-TakanakaJapan Agency for Medical Research and Development (AMED-CREST), AMED, 1-7-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
Hiromi WadaIsotope Science Center, The University of Tokyo, Tokyo, 113-0032, Japan.
Shinzo OhtaBrain Attack Center, Ohta Memorial Hospital, Fukuyama, 720-0825, Japan.
Masanori AikawaThe Center for Excellence in Vascular Biology and the Center for Interdisciplinary Cardiovascular Sciences, Cardiovascular Division and Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Hiroyuki NakajimaDepartment of Cardiovascular Surgery, Saitama Medical University International Medical Center, Saitama, 350-1298, Japan.
Masaki NakamuraDepartment of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan.
Rebecca C McGeeLifeline Cell Technology, Frederick, MD, 21701, USA.
Kyle W HeppnerLifeline Cell Technology, Frederick, MD, 21701, USA.
Tatsuo KawakatsuBio-Medical Department, Kurabo Industries Ltd., Neyagawa, Osaka, 572-0823, Japan.
Michiru GennoBio-Medical Department, Kurabo Industries Ltd., Neyagawa, Osaka, 572-0823, Japan.
Hiroshi YanaseBio-Medical Department, Kurabo Industries Ltd., Neyagawa, Osaka, 572-0823, Japan.
Haruki KumeDepartment of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan.
Takaaki SenbonmatsuDepartment of Cardiology, Saitama Medical University International Medical Center, Saitama, 350-1298, Japan.
Yukio HommaDepartment of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-8655, Japan.
Shigeyuki NishimuraDepartment of Cardiology, Saitama Medical University International Medical Center, Saitama, 350-1298, Japan.
Toutai MitsuyamaJapan Agency for Medical Research and Development (AMED-CREST), AMED, 1-7-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
Hiroyuki AburataniJapan Agency for Medical Research and Development (AMED-CREST), AMED, 1-7-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan.
Hiroshi KimuraJapan Agency for Medical Research and Development (AMED-CREST), AMED, 1-7-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan. hkimura@bio.titech.ac.jp.
Katsuhiko ShirahigeJapan Agency for Medical Research and Development (AMED-CREST), AMED, 1-7-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan. kshirahi@iam.u-tokyo.ac.jp.
The University of Tokyo · JPJapan Agency for Medical Research and Development · JPSaitama Medical University · JPTokyo Institute of Technology · JPBrigham and Women's Hospital · USJichi Medical University · JP

Funding

Japan Agency for Medical Research and Development JP16gm0510005h0006Japan Agency for Medical Research and Development JP19am0101105Japan Society for the Promotion of Science 17H06331Japan Society for the Promotion of Science JP18H05527
6 · The paper itself

Abstract

backgroundEndothelial cells (ECs) make up the innermost layer throughout the entire vasculature. Their phenotypes and physiological functions are initially regulated by developmental signals and extracellular stimuli. The underlying molecular mechanisms responsible for the diverse phenotypes of ECs from different organs are not well understood.

resultsTo characterize the transcriptomic and epigenomic landscape in the vascular system, we cataloged gene expression and active histone marks in nine types of human ECs (generating 148 genome-wide datasets) and carried out a comprehensive analysis with chromatin interaction data. We developed a robust procedure for comparative epigenome analysis that circumvents variations at the level of the individual and technical noise derived from sample preparation under various conditions. Through this approach, we identified 3765 EC-specific enhancers, some of which were associated with disease-associated genetic variations. We also identified various candidate marker genes for each EC type. We found that the nine EC types can be divided into two subgroups, corresponding to those with upper-body origins and lower-body origins, based on their epigenomic landscape. Epigenomic variations were highly correlated with gene expression patterns, but also provided unique information. Most of the deferentially expressed genes and enhancers were cooperatively enriched in more than one EC type, suggesting that the distinct combinations of multiple genes play key roles in the diverse phenotypes across EC types. Notably, many homeobox genes were differentially expressed across EC types, and their expression was correlated with the relative position of each organ in the body. This reflects the developmental origins of ECs and their roles in angiogenesis, vasculogenesis and wound healing.

conclusionsThis comprehensive analysis of epigenome characterization of EC types reveals diverse transcriptional regulation across human vascular systems. These datasets provide a valuable resource for understanding the vascular system and associated diseases.

Indexed as

EpigenomeGene Expression RegulationChromatinDatabases, GeneticEndothelial CellsEnhancer Elements, GeneticGenome-Wide Association StudyHistone CodeHistonesHomeodomain ProteinsHumansPrincipal Component AnalysisPromoter Regions, GeneticChromatinHistonesHomeodomain ProteinsChIP-seqEndothelial cellsEpigenome databaseHistone modificationsLarge-scale analysis

Identifiers

PMID31856914
PMCPMC6921469
OpenAlexW2996042072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.